Treatment of TK2 Deficiency With Thymidine and Deoxycytidine

Clinical trial NCT03639701 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03639701
Sponsor: Columbia University
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Mitochondrial DNA Depletion Syndrome 2 Myopathic Type Thymidine Kinase 2 Deficiency

Start date: 2017-05-16
Primary completion: 2026-12-31
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.